506 related articles for article (PubMed ID: 34481464)
1. Prevalence of undetectable and suppressed viral load in HIV-infected pregnant women initiating Option B+ in Uganda: an observational study nested within a randomized controlled trial.
Gabagaya G; Rukundo G; Amone A; Wavamunno P; Namale-Matovu J; Lubega I; Nakabiito C; Namukwaya Z; Nolan M; Malamba SS; King R; Homsy J; Fowler MG; Musoke P
BMC Infect Dis; 2021 Sep; 21(1):907. PubMed ID: 34481464
[TBL] [Abstract][Full Text] [Related]
2. Enhanced peer-group strategies to support the prevention of mother-to-child HIV transmission leads to increased retention in care in Uganda: A randomized controlled trial.
Amone A; Gabagaya G; Wavamunno P; Rukundo G; Namale-Matovu J; Malamba SS; Lubega I; Homsy J; King R; Nakabiito C; Namukwaya Z; Fowler MG; Musoke P
PLoS One; 2024; 19(4):e0297652. PubMed ID: 38640123
[TBL] [Abstract][Full Text] [Related]
3. Time to first viral load testing among pregnant women living with HIV initiated on option B+ at 5 government clinics in Kampala city, Uganda: Retrospective cohort study.
Atuhaire P; Matovu F; Nakalega R; Kataike H; Nabwana M; Lukyamuzi Z; Guwattude D
Int J Infect Dis; 2021 Mar; 104():526-531. PubMed ID: 33434664
[TBL] [Abstract][Full Text] [Related]
4. Long-term virological outcomes in women who started option B+ care during pregnancy for prevention of mother-to-child transmission of HIV in Dar es Salaam, Tanzania: a cohort study.
Lyatuu GW; Mwashemele SZ; Urrio R; Naburi H; Kashmir N; Machumi L; Kibao A; Sellah Z; Ulenga N; Orsini N; Biberfeld G; Kilewo C; Ekström AM
Lancet HIV; 2021 May; 8(5):e256-e265. PubMed ID: 33581776
[TBL] [Abstract][Full Text] [Related]
5. Detectable Viral Load in Late Pregnancy among Women in the Rwanda Option B+ PMTCT Program: Enrollment Results from the Kabeho Study.
Gill MM; Hoffman HJ; Bobrow EA; Mugwaneza P; Ndatimana D; Ndayisaba GF; Baribwira C; Guay L; Asiimwe A
PLoS One; 2016; 11(12):e0168671. PubMed ID: 28006001
[TBL] [Abstract][Full Text] [Related]
6. Same-day antiretroviral therapy (ART) initiation in pregnancy is not associated with viral suppression or engagement in care: A cohort study.
Langwenya N; Phillips TK; Brittain K; Zerbe A; Abrams EJ; Myer L
J Int AIDS Soc; 2018 Jun; 21(6):e25133. PubMed ID: 29939483
[TBL] [Abstract][Full Text] [Related]
7. HIV genotypic resistance among pregnant women initiating ART in Uganda: a baseline evaluation of participants in the Option B+ clinical trial.
Amone A; Wavamunno P; Gabagaya G; Rukundo G; Namale-Matovu J; Malamba SS; Lubega I; Homsy J; King R; Nakabiito C; Nolan M; Fowler MG; Musoke P
Afr Health Sci; 2022 Dec; 22(4):428-434. PubMed ID: 37092059
[TBL] [Abstract][Full Text] [Related]
8. Decreased emergence of HIV-1 drug resistance mutations in a cohort of Ugandan women initiating option B+ for PMTCT.
Machnowska P; Hauser A; Meixenberger K; Altmann B; Bannert N; Rempis E; Schnack A; Decker S; Braun V; Busingye P; Rubaihayo J; Harms G; Theuring S
PLoS One; 2017; 12(5):e0178297. PubMed ID: 28562612
[TBL] [Abstract][Full Text] [Related]
9. Low detectable postpartum viral load is associated with HIV transmission in Malawi's prevention of mother-to-child transmission programme.
Landes M; van Lettow M; Nkhoma E; Tippett Barr B; Truwah Z; Shouten E; Jahn A; Auld A; Kalua T; van Oosterhout JJ
J Int AIDS Soc; 2019 Jun; 22(6):e25290. PubMed ID: 31180186
[TBL] [Abstract][Full Text] [Related]
10. Optimal timing of viral load monitoring during pregnancy to predict viraemia at delivery in HIV-infected women initiating ART in South Africa: a simulation study.
Lesosky M; Glass T; Mukonda E; Hsiao NY; Abrams EJ; Myer L
J Int AIDS Soc; 2017 Nov; 20 Suppl 7(Suppl 7):. PubMed ID: 29171179
[TBL] [Abstract][Full Text] [Related]
11. Viral Suppression and Retention in Care up to 5 Years After Initiation of Lifelong ART During Pregnancy (Option B+) in Rural Uganda.
Koss CA; Natureeba P; Kwarisiima D; Ogena M; Clark TD; Olwoch P; Cohan D; Okiring J; Charlebois ED; Kamya MR; Havlir DV
J Acquir Immune Defic Syndr; 2017 Mar; 74(3):279-284. PubMed ID: 27828878
[TBL] [Abstract][Full Text] [Related]
12. Effects of M-DEPTH Model of Depression Care on Maternal HIV Viral Suppression and Adherence to the PMTCT Care Continuum Among HIV-Infected Pregnant Women in Uganda: Results from a Cluster Randomized Controlled Trial at Pregnancy Completion.
Wagner GJ; Gwokyalya V; Faherty L; Akena D; Nakigudde J; Ngo V; McBain R; Ghosh-Dastidar B; Beyeza-Kashesya J; Nakku J; Kyohangirwe L; Nabitaka LK; Lukwata H; Mukasa B; Wanyenze RK
AIDS Behav; 2023 Sep; 27(9):2902-2914. PubMed ID: 36907945
[TBL] [Abstract][Full Text] [Related]
13. HIV viral suppression among pregnant and breastfeeding women in routine care in the Kinshasa province: a baseline evaluation of participants in CQI-PMTCT study.
Yotebieng M; Mpody C; Ravelomanana NL; Tabala M; Malongo F; Kawende B; Ntangu P; Behets F; Okitolonda E;
J Int AIDS Soc; 2019 Sep; 22(9):e25376. PubMed ID: 31496051
[TBL] [Abstract][Full Text] [Related]
14. Virologic response of treatment experienced HIV-infected Ugandan children and adolescents on NNRTI based first-line regimen, previously monitored without viral load.
Kibalama Ssemambo P; Nalubega-Mboowa MG; Owora A; Serunjogi R; Kironde S; Nakabuye S; Ssozi F; Nannyonga M; Musoke P; Barlow-Mosha L
BMC Pediatr; 2021 Mar; 21(1):139. PubMed ID: 33752636
[TBL] [Abstract][Full Text] [Related]
15. Viral load suppression after intensive adherence counselling among adult people living with HIV at Kiswa health centre, Kampala: a retrospective cohort study. Secondary data analysis.
Nakaye C; Mukiza N; Mawanda D; Kataike H; Kaganzi H; Ahimbisibwe GM; Businge GB; Kyambadde RC; Nakalega R
AIDS Res Ther; 2023 Mar; 20(1):18. PubMed ID: 36998004
[TBL] [Abstract][Full Text] [Related]
16. Adherence to HIV antiretroviral therapy among pregnant and postpartum women during the Option B+ era: 12-month cohort study in urban South Africa and rural Uganda.
Matthews LT; Orrell C; Bwana MB; Tsai AC; Psaros C; Asiimwe S; Amanyire G; Musinguzi N; Bell K; Bangsberg DR; Haberer JE;
J Int AIDS Soc; 2020 Aug; 23(8):e25586. PubMed ID: 32820622
[TBL] [Abstract][Full Text] [Related]
17. Optimizing prevention of HIV mother to child transmission: Duration of antiretroviral therapy and viral suppression at delivery among pregnant Malawian women.
Chagomerana MB; Miller WC; Tang JH; Hoffman IF; Mthiko BC; Phulusa J; John M; Jumbe A; Hosseinipour MC
PLoS One; 2018; 13(4):e0195033. PubMed ID: 29614083
[TBL] [Abstract][Full Text] [Related]
18. HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South Africa.
Teasdale CA; Sogaula N; Yuengling KA; Wang C; Mutiti A; Arpadi S; Nxele M; Pepeta L; Mogashoa M; Rivadeneira ED; Abrams EJ
J Int AIDS Soc; 2018 Aug; 21(8):e25168. PubMed ID: 30094952
[TBL] [Abstract][Full Text] [Related]
19. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
Kourtis AP; Wiener J; King CC; Heffron R; Mugo NR; Nanda K; Pyra M; Donnell D; Celum C; Lingappa JR; Baeten JM;
J Acquir Immune Defic Syndr; 2017 Jan; 74(1):38-43. PubMed ID: 27787340
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Peer-Group strategies to support prevention of Mother-to-Child HIV transmission leads to increased retention in care in Uganda: A Randomized controlled trial.
Amone A; Gabagaya G; Wavamunno P; Rukundo G; Namale-Matovu J; Malamba SS; Lubega I; Homsy J; King R; Nakabiito C; Namukwaya Z; Fowler MG; Musoke P
medRxiv; 2023 Apr; ():. PubMed ID: 37131665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
